ProNAi Therapeutics (DNAI) Stock: Here’s What You Need To Know
ProNAi Therapeutics (NASDAQ:DNAI) On August 12, 2016 ProNAi Therapeutics had finally completely dropped its PNT2258 drug from its pipeline. It has been a long tough road for the company, who reported its failed phase 2 results at the ASCO meeting held in June. The study reported was known as the “Wolverine” trial, and it treated … Read more